Shares of Hims & Hers Health (NYSE:HIMS) climbed as much as 7.2% in premarket trading on Thursday, building on a 10% surge recorded during Wednesday’s session. The stock is now on track to post gains for a fourth consecutive day.
By the close of trading on Wednesday, the company’s shares had already surged about 64% for the week, putting the stock on course for its strongest weekly performance on record.
The sharp rally began on Monday after reports that Novo Nordisk plans to distribute its weight-loss medications through the Hims platform, boosting investor optimism around the company’s growth prospects.